Daxia Trials Inc
Clinical research center and biobanking service offering IRB‑approved biospecimen collection and customized biological sample services, clinical site services for Phase II/III trials, and patient recruitment and engagement support. The organization reports regulatory and quality program certifications and provides infusion clinic services for research and concierge IV treatments.
Industries
Nr. of Employees
small (1-50)
Daxia Trials Inc
Products
Banked biospecimen inventory
Stored banked blood‑based samples and matched sets of plasma and serum available as test remnants or IRB‑collected material (volumes from 0.5 mL to 25 mL and matched sets).
Prospective collection services
Custom prospective collections of blood, swabs, stool, urine and other specimen types with processing and storage tailored to client protocols.
Plasmapheresis donor material
Disease‑state plasmapheresis material provided under IRB approval for non‑injectable research uses.
Banked biospecimen inventory
Stored banked blood‑based samples and matched sets of plasma and serum available as test remnants or IRB‑collected material (volumes from 0.5 mL to 25 mL and matched sets).
Prospective collection services
Custom prospective collections of blood, swabs, stool, urine and other specimen types with processing and storage tailored to client protocols.
Plasmapheresis donor material
Disease‑state plasmapheresis material provided under IRB approval for non‑injectable research uses.
Services
Prospective and banked collections of blood, plasma, serum, swabs, stool, urine and other specimen types under IRB‑approved protocols with protocol‑specific processing, storage and shipment.
Collection and distribution of plasmapheresis material from disease‑state donors for non‑injectable diagnostic research under IRB approval.
Site network services for Phase II and Phase III investigational therapy trials across multiple therapeutic areas.
Infusion therapy center available for clinical research IV visits and concierge IV treatments.
Design and execution of recruitment and retention programs including direct physician access, digital advertising, community outreach and advisory board support.
Use of existing IRB‑approved protocols and new IRB submissions for specimen collection and study activities (5–7 business day turnaround for new submissions stated).
Prospective and banked collections of blood, plasma, serum, swabs, stool, urine and other specimen types under IRB‑approved protocols with protocol‑specific processing, storage and shipment.
Collection and distribution of plasmapheresis material from disease‑state donors for non‑injectable diagnostic research under IRB approval.
Site network services for Phase II and Phase III investigational therapy trials across multiple therapeutic areas.
Infusion therapy center available for clinical research IV visits and concierge IV treatments.
Design and execution of recruitment and retention programs including direct physician access, digital advertising, community outreach and advisory board support.
Use of existing IRB‑approved protocols and new IRB submissions for specimen collection and study activities (5–7 business day turnaround for new submissions stated).
Expertise Areas
- Clinical trial management (Phase II/III)
- Biobanking and biospecimen services
- Biospecimen processing and logistics
- Patient recruitment and retention
Key Technologies
- Biobanking and controlled specimen storage
- Plasmapheresis
- Customized blood collection and processing
- Clinical data capture and analytics